Guest: Terry P. Mamounas, MD <br>


  <p>How have locoregional, adjuvant, and neoadjuvant therapies for early breast cancer changed? Dr. Mamounas, Medical Director of the Comprehensive Breast Program at Orlando Health UF Health Cancer Center, tells us about therapeutic developments for early breast cancer that were discussed at the 2020 San Antonio Breast Cancer Symposium.</p>

Guest: Terry P. Mamounas, MD How have locoregional, adjuvant, and neoadjuvant therapies for early breast cancer changed? Dr. Mamounas, Medical Director of the Comprehensive Breast Program at Orlando Health UF Health Cancer Center, tells us about therapeutic developments for early breast cancer that were discussed at the 2020 San Antonio Breast Cancer Symposium.

Assessing Advancements in Early Breast Cancer Therapy

As the second most common cancer among American women, breast cancer takes a heavy toll on our patients and our healthcare system as a whole. And since research efforts are constantly devoted to finding innovative diagnostic and treatment strategies, this Breaking Boundaries in Breast Cancer features the latest updates gathered from conferences held around the world and from top experts in the field.

Share Assessing Advancements in Early Breast Cancer Therapy

Sign up to save your podcasts

Assessing Advancements in Early Breast Cancer Therapy

Assessing Advancements in Early Breast Cancer Therapy